Marker Therapeutics Inc.
MRKR | NASDAQ
$1.20
+$0.02 (+1.69%)
At close: Sep 21, 2026, 4:00 PM ET
$1.16
-$0.04 (-3.38%)
Pre-market:
Sep 22, 2026, 7:25 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.23M | 2.09M | 2.44M | 4.69M | 5.39M | 5.7M | 6.59M | 5.4M | 3.73M | 3.32M | 3.31M | 3.01M | 3.76M | 3.78M | 3.51M | 4M | 3M | 2.21M | 1.24M | n/a | n/a | 466.79K |
Cost of Revenue | 5.19M | 9.37M | 9.66M | 14.74M | 15.87M | 14.03M | 13.47M | 11M | 9.57M | 9.62M | 10.42M | 9.98M | 11.53M | 12.07M | 9.53M | 8.17M | 5.38M | 3.24M | 3.16M | 2.81M | 2.39M | 5.89M |
Gross Profit | -3.96M | -7.27M | -7.22M | -10.05M | -10.48M | -8.33M | -6.88M | -5.6M | -5.85M | -6.29M | -7.11M | -6.97M | -7.77M | -8.29M | -6.02M | -4.17M | -2.39M | -1.04M | -1.92M | -2.81M | -2.39M | -5.42M |
Operating Income | -10.71M | -12.35M | -12.89M | -14.87M | -15.13M | -13.18M | -11.12M | -10.19M | -10.99M | -12.82M | -14.58M | -14.68M | -17.31M | -18.44M | -23.93M | -30.65M | -34.85M | -40.49M | -39.48M | -38.22M | -35.57M | -31.02M |
Interest Income | 549.14K | 564.61K | 594.21K | 502.32K | 455.94K | 443.3K | 437.01K | 564.6K | 691.01K | 610.7K | 539.16K | 447.23K | 328.89K | 329.6K | 248.06K | 139.62K | 40.66K | 7.28K | 5.7K | 5.98K | 9.86K | 23.31K |
Pretax Income | -8.72M | -10.91M | -12.18M | -14.25M | -14.56M | -12.73M | -10.68M | -9.63M | -10.3M | -12.21M | -14.04M | -14.35M | -17.09M | -18.23M | -23.91M | -30.63M | -37.34M | -43.01M | -41.88M | -40.62M | -35.56M | -31M |
Net Income | -8.71M | -10.9M | -12.16M | -14.3M | -14.61M | -12.78M | -10.73M | -9.7M | -10.37M | -5.66M | -8.24M | -9.29M | -13.23M | -24.99M | -29.93M | -35.84M | -41.35M | -43.01M | -41.88M | -40.62M | -35.56M | -31M |
Selling & General & Admin | 4.24M | 4.05M | 4.18M | 4.37M | 4.2M | 4.39M | 4.24M | 4.59M | 5.15M | 6.53M | 7.48M | 7.71M | 9.54M | 10.15M | 10.88M | 11.44M | 10.64M | 10.28M | 9.76M | 9.65M | 9.4M | 9.17M |
Research & Development | 8.81M | 11.51M | 11.8M | 14.74M | 15.87M | 14.03M | 13.47M | 11M | 9.57M | 9.62M | 10.42M | 9.98M | 11.53M | 12.07M | 15.72M | 21.56M | 24.75M | 29.18M | 27.79M | 25.76M | 23.78M | 20.71M |
Other Expenses | -6.29M | -10.47M | -10.31M | -14.29M | -15.42M | -13.57M | -13.47M | -11M | -9.57M | -9.62M | -10.42M | -9.98M | -11.53M | -12.07M | -8.7M | -6.52M | -2.92M | n/a | n/a | n/a | n/a | -4.28M |
Operating Expenses | 6.76M | 5.08M | 5.68M | 4.82M | 4.65M | 4.85M | 4.24M | 4.59M | 5.15M | 6.53M | 7.48M | 7.71M | 9.54M | 10.15M | 17.91M | 26.48M | 32.46M | 39.46M | 37.56M | 35.41M | 33.18M | 25.6M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 9.33M | 14.45M | 15.33M | 19.56M | 20.52M | 18.87M | 17.71M | 15.59M | 14.72M | 16.14M | 17.89M | 17.7M | 21.06M | 22.23M | 27.44M | 34.65M | 37.85M | 42.7M | 40.72M | 38.22M | 35.57M | 31.49M |
Income Tax Expense | -15.16K | -15.16K | -15.16K | 49.95K | 49.95K | 49.95K | 49.95K | 3.68K | 3.68K | 3.68K | 3.68K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 19.31M | 19.31M | 15.31M | 16.76M | 13.96M | 11.11M | 9.1M | 8.92M | 8.92M | 8.9M | 8.9M | 8.83M | 8.8M | 8.72M | 8.4M | 8.36M | 8.36M | 8.31M | 8.17M | 8.29M | 8.3M | 5.65M |
Shares Outstanding (Diluted) | 19.31M | 19.31M | 15.31M | 16.76M | 13.96M | 11.11M | 9.1M | 8.92M | 8.92M | 8.9M | 8.9M | 8.83M | 8.8M | 8.72M | 8.4M | 8.36M | 8.36M | 8.31M | 8.32M | 8.31M | 8.3M | 5.65M |
EPS (Basic) | -0.47 | -0.67 | -0.91 | -1.23 | -1.37 | -1.33 | -1.20 | -1.09 | -1.17 | -0.63 | -0.93 | -1.10 | -1.59 | -2.99 | -3.61 | -4.32 | -4.99 | -5.18 | -5.59 | -6.15 | -6.25 | -6.35 |
EPS (Diluted) | -0.47 | -0.67 | -0.91 | -1.23 | -1.37 | -1.33 | -1.20 | -1.09 | -1.17 | -0.63 | -0.93 | -1.10 | -1.59 | -2.99 | -3.61 | -4.30 | -4.97 | -5.16 | -5.57 | -6.15 | -6.25 | -6.35 |
EBITDA | -9.52M | -10.91M | -7.73M | -9.8M | -10.11M | -5.98M | -5.82M | -4.08M | -4.05M | -7.45M | -11.01M | -11.2M | -13.82M | -15.2M | -20.87M | -27.58M | -34.3M | -39.77M | -38.72M | -37.81M | -33.17M | -29.32M |
EBIT | -6.9M | -10.91M | -11.89M | -13.96M | -14.27M | -12.44M | -10.68M | -9.63M | -10.3M | -12.21M | -14.04M | -14.35M | -17.09M | -18.23M | -23.91M | -30.63M | -37.34M | -43.01M | -41.88M | -40.62M | -35.56M | -31.02M |
Depreciation & Amortization | n/a | 3 | 4.16M | 4.16M | 4.16M | 6.46M | 4.86M | 5.55M | 6.25M | 4.76M | 3.03M | 3.15M | 3.27M | 3.03M | 3.05M | 3.05M | 3.04M | 3.24M | 3.16M | 2.81M | 2.39M | 1.7M |
Add to Watchlist
Select watchlists to add or remove MRKR